New formulation helps RNA vaccines withstand high temperatures
RNA vaccines, which have proved effective against COVID-19, are now being developed for many other diseases, including cancer. One drawback is that they require ultracold storage, but MIT researchers have found a promising way to overcome that limitation.
Image: Phys.org
RNA vaccines, which have proved effective against COVID-19, are now being developed for many other diseases, including cancer. One drawback is that they require ultracold storage, but MIT researchers have found a promising way to overcome that limitation.
Originally published at Phys.org
